Natixis Advisors, L.P. Incyte Corp Transaction History
Natixis Advisors, L.P.
- $54.1 Billion
- Q1 2025
A detailed history of Natixis Advisors, L.P. transactions in Incyte Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 35,703 shares of INCY stock, worth $2.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,703
Previous 24,905
43.36%
Holding current value
$2.5 Million
Previous $1.72 Million
25.7%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding INCY
# of Institutions
695Shares Held
194MCall Options Held
564KPut Options Held
331K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.15 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.49 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.4 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$1.04 Billion0.55% of portfolio
-
State Street Corp Boston, MA10MShares$701 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $15.5B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...